CATX - Perspective Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.86 0.14 (2.88%) --- -0.01 (-0.2%) 0.0 (0.0%) 0.09 (1.85%) 0.1 (2.04%) -0.06 (-1.19%) -0.06 (-1.19%)

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.25
Diluted EPS:
-0.25
Basic P/E:
-20.0
Diluted P/E:
-20.0
RSI(14) 1m:
48.85
VWAP:
5.01
RVol:
0.8788

Events

Period Kind Movement Occurred At
1m Price increase 1m 5.05 +0.1 (+1.95%) Oct 15 09:31
1m Price increase 1m 4.98 +0.08 (+1.63%) Oct 15 09:30

Related News